140 related articles for article (PubMed ID: 17334352)
1. Immunoglobulin VH gene analysis in gastric MALT lymphomas.
Sakuma H; Nakamura T; Uemura N; Chiba T; Sugiyama T; Asaka M; Akamatsu T; Ueda R; Eimoto T; Goto H; Nakamura S; Inagaki H
Mod Pathol; 2007 Apr; 20(4):460-6. PubMed ID: 17334352
[TBL] [Abstract][Full Text] [Related]
2. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion.
Inagaki H; Nakamura T; Li C; Sugiyama T; Asaka M; Kodaira J; Iwano M; Chiba T; Okazaki K; Kato A; Ueda R; Eimoto T; Okamoto S; Sasaki N; Uemura N; Akamatsu T; Miyabayashi H; Kawamura Y; Goto H; Niwa Y; Yokoi T; Seto M; Nakamura S
Am J Surg Pathol; 2004 Dec; 28(12):1560-7. PubMed ID: 15577674
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
[TBL] [Abstract][Full Text] [Related]
5. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y
Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic comparison between the API2-MALT1 chimeric transcript-positive and -negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
Nakamura T; Nakamura S; Yokoi T; Suzuki H; Ohashi K; Seto M
Jpn J Cancer Res; 2002 Jun; 93(6):677-84. PubMed ID: 12079516
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
[TBL] [Abstract][Full Text] [Related]
8. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
Liu H; Ye H; Ruskone-Fourmestraux A; De Jong D; Pileri S; Thiede C; Lavergne A; Boot H; Caletti G; Wündisch T; Molina T; Taal BG; Elena S; Thomas T; Zinzani PL; Neubauer A; Stolte M; Hamoudi RA; Dogan A; Isaacson PG; Du MQ
Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515
[TBL] [Abstract][Full Text] [Related]
9. E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response.
Liu TY; Chen SU; Kuo SH; Cheng AL; Lin CW
Mod Pathol; 2010 Nov; 23(11):1507-17. PubMed ID: 20802470
[TBL] [Abstract][Full Text] [Related]
10. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma.
Dong G; Liu C; Ye H; Gong L; Zheng J; Li M; Huang X; Huang X; Huang Y; Shi Y; Yin W; Gao Z
Int J Hematol; 2008 Dec; 88(5):516-523. PubMed ID: 18949449
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori eradication therapy.
Alpen B; Thiede C; Wündisch T; Bayerdörffer E; Stolte M; Neubauer A
Clin Lymphoma; 2001 Sep; 2(2):103-8. PubMed ID: 11707850
[TBL] [Abstract][Full Text] [Related]
12. Analysis of API2-MALT1 fusion, trisomies, and immunoglobulin VH genes in pulmonary mucosa-associated lymphoid tissue lymphoma.
Xia H; Nakayama T; Sakuma H; Yamada S; Sato F; Takino H; Okabe M; Fujiyoshi Y; Hattori H; Inagaki H
Hum Pathol; 2011 Sep; 42(9):1297-304. PubMed ID: 21396678
[TBL] [Abstract][Full Text] [Related]
13. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs.
Iwano M; Okazaki K; Uchida K; Nakase H; Ohana M; Matsushima Y; Inagaki H; Chiba T
J Gastroenterol; 2004 Aug; 39(8):739-46. PubMed ID: 15338367
[TBL] [Abstract][Full Text] [Related]
15. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.
Liu H; Ruskon-Fourmestraux A; Lavergne-Slove A; Ye H; Molina T; Bouhnik Y; Hamoudi RA; Diss TC; Dogan A; Megraud F; Rambaud JC; Du MQ; Isaacson PG
Lancet; 2001 Jan; 357(9249):39-40. PubMed ID: 11197361
[TBL] [Abstract][Full Text] [Related]
16. API2-MALT1 fusion gene in colorectal lymphoma.
Sakugawa ST; Yoshino T; Nakamura S; Inagaki H; Sadahira Y; Nakamine H; Okabe M; Ichimura K; Tanimoto M; Akagi T
Mod Pathol; 2003 Dec; 16(12):1232-41. PubMed ID: 14681324
[TBL] [Abstract][Full Text] [Related]
17. Changes in pattern of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Kanda M; Suzumiya J; Ohshima K; Okada M; Tamura K; Kikuchi M
Leuk Lymphoma; 2001 Aug; 42(4):639-47. PubMed ID: 11697492
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
[TBL] [Abstract][Full Text] [Related]
19. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
Nakamura T; Inagaki H; Seto M; Nakamura S
J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
[TBL] [Abstract][Full Text] [Related]
20. Effect of Helicobacter pylori eradication on ongoing mutation of immunoglobulin genes in gastric MALT lymphoma.
Fujimori K; Shimodaira S; Akamatsu T; Furihata K; Katsuyama T; Hosaka S
Br J Cancer; 2005 Jan; 92(2):312-9. PubMed ID: 15655559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
